Revised Professional Labeling for Medicines Proposed by FDA

The FDA proposed a new format for prescription medicine package inserts that would allow practitioners “to quickly find the most important information about the product,” according to HHS. The redesigned information should “enhance the safe and effective use of prescription drugs and reduce medical errors caused by inadequate communication.” Comments on the Dec. 22 Federal Register notice are due March 22, 2001.